Data from Federal Scientists Raise Questions About J.&J. Booster Shots
People who have received the company’s one-shot vaccine may benefit from a booster with another brand. F.D.A. advisers will discuss the data on Friday.
View original article
Contributor: Carl Zimmer and Noah Weiland
